This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1995 Feb;7(2):99-110.

doi: 10.2165/00019053-199507020-00002.

Preventing NSAID-induced gastrointestinal toxicity. Economic considerations, methodological problems and results

G de Pouvourville¹

Affiliations

PMID: 10155306
DOI: 10.2165/00019053-199507020-00002

Review

Preventing NSAID-induced gastrointestinal toxicity. Economic considerations, methodological problems and results

G de Pouvourville. Pharmacoeconomics. 1995 Feb.

. 1995 Feb;7(2):99-110.

doi: 10.2165/00019053-199507020-00002.

Author

G de Pouvourville¹

Affiliation

¹ Centre de Recherche en Gestion, Ecole Polytechnique, Paris, France.

PMID: 10155306
DOI: 10.2165/00019053-199507020-00002

No abstract available

PubMed Disclaimer

Similar articles

Cost-effectiveness of misoprostol for prophylaxis against nonsteroidal anti-inflammatory drug-induced gastrointestinal tract bleeding.
Edelson JT, Tosteson AN, Sax P. Edelson JT, et al. JAMA. 1990 Jul 4;264(1):41-7. JAMA. 1990. PMID: 2113103
How to evaluate drugs. Cost-effectiveness analysis.
Beck JR. Beck JR. JAMA. 1990 Jul 4;264(1):83-4. JAMA. 1990. PMID: 2113106 No abstract available.
NSAID association with gastrointestinal bleeding and peptic ulcer.
Hirschowitz BI, Lanas A. Hirschowitz BI, et al. Agents Actions Suppl. 1991;35:93-101. Agents Actions Suppl. 1991. PMID: 1781426 Review.
The cost-effectiveness of misoprostol for nonsteroidal antiinflammatory drug-associated adverse gastrointestinal events.
Gabriel SE, Jaakkimainen RL, Bombardier C. Gabriel SE, et al. Arthritis Rheum. 1993 Apr;36(4):447-59. doi: 10.1002/art.1780360404. Arthritis Rheum. 1993. PMID: 8457220
[Critical evaluation of economic analysis exemplified by preventive misoprostol administration in antirheumatic drug-induced gastropathy].
Stucki G, Sangha O. Stucki G, et al. Z Rheumatol. 1994 Jan-Feb;53(1):37-45. Z Rheumatol. 1994. PMID: 8165876 Review. German.

See all similar articles

Cited by

Diclofenac/misoprostol. A review of its pharmacology and therapeutic efficacy in painful inflammatory conditions.
Davis R, Yarker YE, Goa KL. Davis R, et al. Drugs Aging. 1995 Nov;7(5):372-93. doi: 10.2165/00002512-199507050-00005. Drugs Aging. 1995. PMID: 8573992 Review.
Systematic review of the cost effectiveness of prophylactic treatments in the prevention of gastropathy in patients with rheumatoid arthritis or osteoarthritis taking non-steroidal anti-inflammatory drugs.
van Dieten HE, Korthals-de Bos IB, van Tulder MW, Lems WF, Dijkmans BA, Boers M. van Dieten HE, et al. Ann Rheum Dis. 2000 Oct;59(10):753-9. doi: 10.1136/ard.59.10.753. Ann Rheum Dis. 2000. PMID: 11005773 Free PMC article.
Pharmacoeconomics of chronic nonmalignant pain.
Zagari MJ, Mazonson PD, Longton WC. Zagari MJ, et al. Pharmacoeconomics. 1996 Oct;10(4):356-77. doi: 10.2165/00019053-199610040-00005. Pharmacoeconomics. 1996. PMID: 10163578 Review.
The cost effectiveness of diclofenac plus misoprostol compared with diclofenac monotherapy in patients with rheumatoid arthritis.
Al MJ, Michel BC, Rutten FF. Al MJ, et al. Pharmacoeconomics. 1996 Aug;10(2):141-51. doi: 10.2165/00019053-199610020-00006. Pharmacoeconomics. 1996. PMID: 10163417 Clinical Trial.
Diclofenac/misoprostol. Pharmacoeconomic implications of therapy.
Plosker GL, Lamb HM. Plosker GL, et al. Pharmacoeconomics. 1999 Jul;16(1):85-98. doi: 10.2165/00019053-199916010-00008. Pharmacoeconomics. 1999. PMID: 10539124 Review.

See all "Cited by" articles

References

1. Scand J Rheumatol Suppl. 1992;92:13-9 - PubMed
1. BMJ. 1988 Oct 22;297(6655):1017-21 - PubMed
1. Gastroenterol Clin Biol. 1989 Mar;13(3):239-44 - PubMed
1. Ann Rheum Dis. 1993 Dec;52(12):881-5 - PubMed
1. Scand J Rheumatol. 1992;21(2):85-91 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information